Results 31 to 40 of about 10,251 (261)

In dogs with congestive heart failure, is torasemide superior to furosemide as a first line diuretic treatment?

open access: yesVeterinary Evidence, 2020
PICO question In dogs with congestive heart failure, does the use of torasemide as a first line diuretic result in a superior survival time when compared to furosemide?
Leo Packham
doaj   +1 more source

Medical treatment of ascites in cirrhosis [PDF]

open access: yes, 1993
Medical treatment of cirrhotic ascites is essentially supportive, dictated by the patient's discomfort, impaired cardiovascular or respiratory function and potential for infection. Treatment of ‘simple’ ascites (moderate fluid accumulation, serum albumin
Alexander L. Gerbes   +41 more
core   +1 more source

Diuretics in modern nephrology

open access: yesPočki, 2019
The paper considers the problem of using loop diuretics in patients with chronic kidney disease associated with cardiovascular risk, such as heart failure, hypertension, edema syndrome, including those against diabetes mellitus. Three therapeutic margins
D.D. Ivanov
doaj   +1 more source

Can we improve the treatment of congestion in heart failure? [PDF]

open access: yes, 2011
INTRODUCTION: Dyspnoea and peripheral oedema, caused by fluid redistribution to the lungs and/or by fluid overload, are the main causes of hospitalization in patients with heart failure and are associated with poor outcomes.
Bettari L   +7 more
core   +1 more source

Torasemide inhibits angiotensin II-induced vasoconstriction and intracellular calcium increase in the aorta of spontaneously hypertensive rats [PDF]

open access: yes, 1999
Torasemide is a loop diuretic that is effective at low once-daily doses in the treatment of arterial hypertension. Because its antihypertensive mechanism of action may not be based entirely on the elimination of salt and water from the body, a ...
Diez-Martinez, J. (Javier)   +6 more
core   +1 more source

A green HPLC method for the determination of torasemide in pharmaceutical dosage forms: Development, validation, and greenness assessment

open access: yesBulletin of the Chemical Society of Ethiopia, 2023
Two HPLC methods were developed for the determination of torasemide in pharmaceutical products. In the first method, a C18 column whose temperature was kept constant at 25 °C was used. A combination of 0.1% formic acid solution in water and acetonitrile (
Erten Akbel   +2 more
semanticscholar   +1 more source

Diuretic therapy effects on the signal-averaged ECG parameters of atrial complex and supraventricular arrhythmias in patients with coronary heart disease and chronic heart failure

open access: yesКардиоваскулярная терапия и профилактика, 2011
Aim. To study the signal-averaged ECG (SA-ECG) parameters of atrial complex and supraventricular arrhythmias (SVA) in patients with coronary heart disease (CHD) and chronic heart failure (CHF), treated with diuretics (D) torasemide and furosemide ...
Kh. Kh. Shugushev, A. A. Gaeva
doaj   +1 more source

Use of loop diuretics in heart failure: Current aspects [PDF]

open access: yesТерапевтический архив, 2017
Loop diuretics take the lead in the treatment of patients with symptomatic heart failure. Torasemide is the most effective and safe loop diuretic with the optimal pharmacokinetic profile, the additional properties associated with simultaneous blockade of
N V Kurlykina   +2 more
doaj   +1 more source

Changes in prescribed medicines in older patients with multimorbidity and polypharmacy in general practice [PDF]

open access: yes, 2018
Background: Treatment complexity rises in line with the number of drugs, single doses, and administration methods, thereby threatening patient adherence. Patients with multimorbidity often need flexible, individualised treatment regimens, but alterations
Buedingen, Fiona von   +5 more
core   +1 more source

4-(3-Methylanilino)-N-[N-(1-methylethyl)carbamoyl]pyridinium-3-sulfonamidate (torasemide) methanol 0.25-solvate 0.25-hydrate

open access: yesActa Crystallographica Section E, 2009
The title compound, C16H20N4O3S·0.25CH4O·0.25H2O, is a hydrate/methanol solvate of torasemide, a diuretic drug used in the treatment of hypertension.
Massimo Di Vaira   +3 more
doaj   +1 more source

Home - About - Disclaimer - Privacy